<p>What professor Louise Emmett really loves is research. As a doctor, she says, you are able to change the lives for some people. With clinical research you can change the lives for millions of people. In this episode Louise Emmett explains theragnostics in prostate cancer and how prostate imaging can be used to understand the phenotype of the tumor. A step towards a more personalized treatment.

Guest: Professor Louise Emmett
By: Gustav Widar and Annette Andrén
Contact us: <a href='mailto:podcast@samnordic.se'>podcast@samnordic.se</a>
For more info, visit<a href='http://www.samnordic.se'> www.samnordic.se</a></p>

Renaissance for radioligand therapy - with Germo Gericke

Very welcome to Theragnostic Talks by SAM Nordic, the one and only podcast about theragnostic. What is even theragnostic? And what does the future for it look like? In this podcast we will find out interesting science and get answers to curious questions by talking with true experts - clinicians, scientists and people from the industry.

And to guide you through these episodes – Annette Andrén and Gustav Widar.

Annette is driven by the transformation of science into value for patients. Her background as a chemical engineer - with focus on biochemistry - has led her to different positions such as country manager and market access director in the Nordics. She has been working both within a large variety of different therapy areas and with breakthrough treatments for inflammation and autoimmune diseases. What she likes the most is when she is able to help out in the identification of scientific opportunities for collaborations between Health care, Research and the Industry. She is currently senior medical science liaison at SAM Nordic.
 
Gustav has a background as a licensed medical physicist and has worked many years in the field of nuclear medicine – covering imaging, therapy and the production of radiopharmaceuticals. He is driven by making medical innovations a clinical reality – where it really benefits the patient care. A couple of years ago he changed from healthcare to industry, now medical science liaison at SAM Nordic.